228 related articles for article (PubMed ID: 19174771)
1. An update on the use of mycophenolate mofetil in lupus nephritis and other primary glomerular diseases.
Appel AS; Appel GB
Nat Clin Pract Nephrol; 2009 Mar; 5(3):132-42. PubMed ID: 19174771
[TBL] [Abstract][Full Text] [Related]
2. Successful mycophenolate mofetil treatment of glomerular disease.
Briggs WA; Choi MJ; Scheel PJ
Am J Kidney Dis; 1998 Feb; 31(2):213-7. PubMed ID: 9469489
[TBL] [Abstract][Full Text] [Related]
3. Lupus nephritis: treatment with mycophenolate mofetil.
Kapitsinou PP; Boletis JN; Skopouli FN; Boki KA; Moutsopoulos HM
Rheumatology (Oxford); 2004 Mar; 43(3):377-80. PubMed ID: 14963204
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil in nonlupus glomerulonephropathy.
Karim MY; Abbs IC
Lupus; 2005; 14 Suppl 1():s39-41. PubMed ID: 15803930
[TBL] [Abstract][Full Text] [Related]
5. Use of mycophenolate mofetil in autoimmune and renal diseases.
Appel GB; Radhakrishnan J; Ginzler EM
Transplantation; 2005 Oct; 80(2 Suppl):S265-71. PubMed ID: 16251859
[TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil in the treatment of glomerular diseases.
Grcevska L; Polenakovic M
Prilozi; 2007 Jul; 28(1):57-68. PubMed ID: 17921918
[TBL] [Abstract][Full Text] [Related]
7. What is the value of mycophenolate mofetil as induction and maintenance therapy in lupus nephritis?
Jones RB; Walsh M; Smith KG
Curr Opin Rheumatol; 2009 May; 21(3):256-61. PubMed ID: 19399995
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil in lupus nephritis.
Ginzler EM; Aranow C
Lupus; 2005; 14(1):59-64. PubMed ID: 15732290
[TBL] [Abstract][Full Text] [Related]
9. The effect of mycophenolate mofetil on primary and secondary treatment of primary glomerulonephritis and lupus nephritis.
Paydas S; Kurt C; Taskapan H; Balal M; Sertdemir Y; Pembegul I
Int Urol Nephrol; 2009; 41(1):145-52. PubMed ID: 18766457
[TBL] [Abstract][Full Text] [Related]
10. Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis.
Moore RA; Derry S
Arthritis Res Ther; 2006; 8(6):R182. PubMed ID: 17163990
[TBL] [Abstract][Full Text] [Related]
11. Treatment for lupus nephritis.
Henderson L; Masson P; Craig JC; Flanc RS; Roberts MA; Strippoli GF; Webster AC
Cochrane Database Syst Rev; 2012 Dec; 12():CD002922. PubMed ID: 23235592
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
Mok CC; Ying KY; Yim CW; Siu YP; Tong KH; To CH; Ng WL
Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339
[TBL] [Abstract][Full Text] [Related]
13. The accumulated experience with the use of mycophenolate mofetil in primary glomerulonephritis.
Koukoulaki M; Goumenos DS
Expert Opin Investig Drugs; 2010 May; 19(5):673-87. PubMed ID: 20374037
[TBL] [Abstract][Full Text] [Related]
14. Lupus nephritis: induction therapy in severe lupus nephritis--should MMF be considered the drug of choice?
Rovin BH; Parikh SV; Hebert LA; Chan TM; Mok CC; Ginzler EM; Hooi LS; Brunetta P; Maciuca R; Solomons N
Clin J Am Soc Nephrol; 2013 Jan; 8(1):147-53. PubMed ID: 22879439
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.
Zhu B; Chen N; Lin Y; Ren H; Zhang W; Wang W; Pan X; Yu H
Nephrol Dial Transplant; 2007 Jul; 22(7):1933-42. PubMed ID: 17405792
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil versus azathioprine as maintenance therapy for lupus nephritis: a meta-analysis.
Feng L; Deng J; Huo DM; Wu QY; Liao YH
Nephrology (Carlton); 2013 Feb; 18(2):104-10. PubMed ID: 23113811
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil therapy in lupus nephritis: clinical observations.
Dooley MA; Cosio FG; Nachman PH; Falkenhain ME; Hogan SL; Falk RJ; Hebert LA
J Am Soc Nephrol; 1999 Apr; 10(4):833-9. PubMed ID: 10203368
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil treatment for therapy-resistant glomerulopathies.
Sahin GM; Sahin S; Kantarci G; Ergin H
Nephrology (Carlton); 2007 Jun; 12(3):285-8. PubMed ID: 17498124
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil in low doses stabilizes and improves antineutrophil cytoplasmic antibody-associated vasculitis and lupus nephritis.
Kazderova M; Jancova E; Rysava R; Merta M; Tesar V
Arch Med Res; 2008 Jan; 39(1):115-9. PubMed ID: 18068004
[TBL] [Abstract][Full Text] [Related]
20. Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy.
Karim MY; Pisoni CN; Ferro L; Tungekar MF; Abbs IC; D'Cruz DP; Khamashta MA; Hughes GR
Rheumatology (Oxford); 2005 Oct; 44(10):1317-21. PubMed ID: 16049051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
